ASCO® GI 2025 Insights: Real-World Evidence of Nanoliposomal Irinotecan + 5FU + Leucovorin in Unresectable or Recurrent Pancreatic Cancer - NAPOLEON-2 Study | VuMedi

Find latest Pancreatic Cancer videos · 100+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

This video is featured in the Insights from 2025 ASCO® GI Annual Meeting

Insights from 2025 ASCO® GI Annual Meeting

ASCO® GI 2025 Insights: Real-World Evidence of Nanoliposomal Irinotecan + 5FU + Leucovorin in Unresectable or Recurrent Pancreatic Cancer - NAPOLEON-2 Study

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Tsuyoshi Shirakawa

By Insights from 2025 ASCO® GI Annual Meeting FEATURING Tsuyoshi Shirakawa

115 views

February 21, 2025

Comments 0

Login to view comments. Click here to Login